Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
04/2006
04/26/2006EP1650189A1 Benzylamine derivative
04/26/2006EP1649872A1 Sheet for guiding regeneration of mesenchymal tissue and production method thereof
04/26/2006EP1649871A1 Retroviral protease inhibitor combinations
04/26/2006EP1649863A1 Composition for lowering serum uric acid level
04/26/2006EP1649857A2 New use of glutamate antagonists for the treatment of cancer
04/26/2006EP1649855A1 Medicinal composition
04/26/2006EP1649849A2 Compositions for the treatment of Parkinson's disease containing a CB1 receptor antagonist and a product that activates the dopaminergic neurotransmission in the brain.
04/26/2006EP1649761A1 Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves
04/26/2006EP1648941A1 Method of processing seaweed
04/26/2006EP1648480A2 Use of botulinum toxin for producing drug for preventing or treating final phase of lung troubles
04/26/2006EP1648437A2 Sirt1 modulators for manipulating cell/organism lifespan/stress response
04/26/2006EP1465852A4 Synthesis of combretastatin a-2 prodrugs
04/26/2006EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
04/26/2006EP1409485B1 Immunomodulating compounds
04/26/2006EP1399144B1 Carbamate compounds for use in preventing or treating anxiety disorders
04/26/2006EP1313509B1 Treatment of tumors with acetylenes disubstituted with an heteroaromatic group and a substituted thiochromanyl group in combination with other anti-tumor agents
04/26/2006EP1294689B1 Preparation method of a novel beta crystalline form of perindopril tert-butylamine salt
04/26/2006EP1244702B1 Process for isolation of osteopontin from milk
04/26/2006EP1210348B9 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
04/26/2006EP1066036B1 Agents with serotonin-related activity for the treatment for sleep apnea
04/26/2006EP1032697B1 High efficiency retroviral vectors that contain none of viral coding sequences
04/26/2006EP1009829B1 Adipocyte-specific protein homologs
04/26/2006EP0966536B1 Factor x analogues with a modified protease cleavage site
04/26/2006EP0811057B1 Viral preparations, vectors, immunogens, and vaccines
04/26/2006CN1764723A Interleukin-18 mutants, their production and use
04/26/2006CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors
04/26/2006CN1764651A Quinazoline derivatives as antitumor agents
04/26/2006CN1764635A carboxylic acid compounds
04/26/2006CN1764467A Hair-darkening liquid preparation capable of making white hair to become black hair and preparing method
04/26/2006CN1764453A Therapeutic formulation for mainly of diarrhea large intesitine irritation syndrome
04/26/2006CN1763097A Polypeptide variants with altered effector function
04/26/2006CN1763028A Novel ascorbic acid compounds, methods of synthesis and application use thereof
04/26/2006CN1763027A Novel ascorbic acid compounds, methods of synthesis and application use thereof
04/26/2006CN1762467A Formula of dried solomonseal and its preparation method
04/26/2006CN1762388A Tasty, refreshing, sterilizing, yin-nourishing health care product or drug formula and preparation method thereof
04/26/2006CN1762369A Vertical transmitted antidysenteric
04/26/2006CN1762355A (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
04/26/2006CN1762338A Treatment method of conduct disorder
04/26/2006CN1253463C Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same
04/26/2006CN1253453C 1-aryl beta-carboline and thio-analog, their preparations and uses in medicines
04/26/2006CN1253452C Thioether subsituted imidazoquinoline compound
04/26/2006CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors
04/26/2006CN1253442C Novel thiazine or pyrazine derivatives
04/26/2006CN1253441C Protease inhibitors
04/26/2006CN1253208C Use of antibodies against CD2O for treatment of graft versus host disease
04/26/2006CN1253204C Biological process for the production of a food product comprising heme-iron and food product obtained with said process
04/26/2006CN1253195C Anti-age capsule of traditional Chinese medicine and preparation method
04/26/2006CN1253192C Medicine for treating summer heat wetness cold and preparing method
04/26/2006CN1253191C Chinese traditional medicine for treating acute and chronic appendicitis
04/26/2006CN1253172C Anti-allergic agents, drugs, foods, or cosmetics containing them and process for producing the same
04/26/2006CN1253158C Luminescent bio-element and preparation process thereof
04/26/2006CN1253152C Single particle nano-garlicin micro-capsule, and its preparation method
04/26/2006CN1253151C Use of MGLUR 5 antagonists for treatment of pruritic conditions
04/26/2006CN1253150C Xa factor inhibitor on its own and/or combined with platelet anti-aggegating agent
04/26/2006CN1253109C Health drink for preventing AIDS
04/25/2006US7034182 Compounds to treat Alzheimer's disease
04/25/2006US7034176 Aminopropylphosphinic acids
04/25/2006US7034160 Anticoagulants, methyl (2R,3R)-2-(3-(amino(imino)methyl)benzyl)-3-((4-(1-oxido-4-pyridinyl) benzoyl)amino)butanoate; therapeutic treatment of cardiovascular disorders
04/25/2006US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease
04/25/2006US7034114 Polypeptide for use in the treatment of inflammation, atherosclerosis, nervous system, blood, muscular, connective tissue and cancer disorders
04/25/2006US7034111 17867, a novel human aminopeptidase
04/25/2006US7034056 Aryl and biaryl compounds having MCH modulatory activity
04/25/2006US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
04/25/2006US7034044 NMDA (N-methyl-D- aspartate)-receptor subtype blockers and are used in the treatment or prevention of CNS disorders i.e. Alzheimer's, Parkinson's, etc.
04/25/2006US7034043 Cell adhesion inhibitors
04/25/2006US7034033 Substituted quinazolinone compounds
04/25/2006US7034032 1,2,3-triazolo(4,5-d)pyrimidine compounds used to treat cardiovascular disorders
04/25/2006US7034031 Modulators of TNF-α signaling
04/25/2006US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers
04/25/2006US7034024 Synergistic mixture of 7-(2-amino-1-oxo-3-thiopropyl)-8-((cyclomethyl)-2-phenyl)-5,6,7,8-tetrahydroimidazolo(1,2-a)pyrazine and cisplatin
04/25/2006US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
04/25/2006US7034020 inactivators of antigen-specific T cells; increased half-life
04/25/2006US7034019 Prodrugs of HIV replication inhibiting pyrimidines
04/25/2006US7034014 Phosphonate compounds
04/25/2006US7034006 Use of lipid conjugates in the treatment of disease
04/25/2006US7034005 Use of macrolide derivatives such as 6,15,16-Trioxatricyclo(10.2.1.11,4) hexadecane, erythromycin derivative
04/25/2006US7034001 Methods of therapy with thrombin derived peptides
04/25/2006US7033812 β-secretase and modulation of β-secretase activity
04/25/2006US7033805 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase.
04/25/2006US7033796 cloned from cDNA library of human liver carcinoma cell line using PCR amplification; host cells
04/25/2006US7033794 Basolateral sorting signal and inhibitors thereof
04/25/2006US7033750 Recombinant P53 adenovirus methods and compositions
04/25/2006US7033615 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
04/25/2006US7033605 performing an ocular transplant procedure; implanting in the eye a biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer.
04/25/2006US7033604 Composition for topical administration
04/25/2006US7033594 Method of treatment using ligand-immunogen conjugates
04/25/2006US7033588 combination of coenzyme Q and a surfactant can prevent ascites even when administering in a small dose and within a short period of time
04/25/2006US7033583 A water soluble polymer conjugated drug containing mercaptan group; controlled pharmacokinetics and improved bioavailability, relative to unmodified bioactive materials
04/25/2006US7033578 Antimycotic nail varnish composition
04/25/2006US7033575 Delivery of physiologically active compounds through an inhalation route
04/25/2006CA2237313C Aromatic carboxylic acid esters, the production of same and use of same as medicaments
04/25/2006CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds
04/20/2006WO2006042104A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
04/20/2006WO2006041197A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ
04/20/2006WO2006041135A1 STAT3 PHOSPHORYLATION INHIBITOR AND Notch1 EXPRESSION INHIBITOR
04/20/2006WO2006041121A1 Remedies/preventives for chronic skin disease
04/20/2006WO2006041046A1 Pyridine derivative
04/20/2006WO2006041037A1 Novel pyridine derivative
04/20/2006WO2006040966A1 Aromatic-ring-fused pyrimidine derivative
04/20/2006WO2006040038A1 Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders